mAbxience is a global CDMO specializing in the development and manufacturing of biologics, helping to accelerate access to high-quality, life-saving medicines. Our end-to-end CDMO services, from cell line development to large-scale production, are designed to meet the unique needs of our partners in the biopharmaceutical industry. With state-of-the-art facilities in Spain and Argentina, we provide agile, flexible, and reliable solutions, guaranteeing seamless tech transfers and fast time-to-market.
mAbxience is driven by our commitment to delivering tailored CDMO solutions that accelerate drug development and ensure the successful supply of our partners’ life-saving medicines.

Type of Drugs Manufactured:

Biologics

CDMO Services:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

3-5

Facilities Locations:

Europe;South America

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);GMP;PMDA (Japan);Health Canada;ANVISA (Brazil)